The New York Times (5/17, LaFraniere) reports that the FDA “authorized booster shots of the Pfizer-BioNTech vaccine on Tuesday for children 5 to 11, the latest in a series of actions intended to bolster waning protection against infection from the coronavirus vaccines.” Over “eight million of the 28 million children in that age group in the United States have received two vaccine shots, and will now be eligible for the extra dose at least five months after their second shot.”